JP2011527695A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527695A5 JP2011527695A5 JP2011517601A JP2011517601A JP2011527695A5 JP 2011527695 A5 JP2011527695 A5 JP 2011527695A5 JP 2011517601 A JP2011517601 A JP 2011517601A JP 2011517601 A JP2011517601 A JP 2011517601A JP 2011527695 A5 JP2011527695 A5 JP 2011527695A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- hydrogen
- formula
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 17
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 125000006239 protecting group Chemical group 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 3
- 239000011612 calcitriol Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- AEDMQUAPBVOJNN-UHFFFAOYSA-N [3-[2-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]-1,3-thiazol-5-yl]-1,2,4-oxadiazol-5-yl]methanol Chemical compound O1C(CO)=NC(C=2SC(=NC=2)N2CCC(CC2)OC=2C(=CC=CC=2)C(F)(F)F)=N1 AEDMQUAPBVOJNN-UHFFFAOYSA-N 0.000 claims 1
- 210000001789 adipocyte Anatomy 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 201000006409 renal osteodystrophy Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 230000037393 skin firmness Effects 0.000 claims 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/171,113 | 2008-07-10 | ||
| US12/171,113 US8193170B2 (en) | 2008-07-10 | 2008-07-10 | 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs |
| PCT/US2009/050048 WO2010006125A2 (en) | 2008-07-10 | 2009-07-09 | 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011527695A JP2011527695A (ja) | 2011-11-04 |
| JP2011527695A5 true JP2011527695A5 (enExample) | 2012-08-23 |
Family
ID=41382480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517601A Pending JP2011527695A (ja) | 2008-07-10 | 2009-07-09 | ２−メチレン−１９，２６−ジノル−（２０ｒ，２２ｅ，２５ｒ）−ビタミンｄ類似物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8193170B2 (enExample) |
| EP (1) | EP2313367A2 (enExample) |
| JP (1) | JP2011527695A (enExample) |
| AU (1) | AU2009268557B2 (enExample) |
| CA (1) | CA2730244A1 (enExample) |
| WO (1) | WO2010006125A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007298651A1 (en) * | 2006-04-06 | 2008-03-27 | Wisconsin Alumni Research Foundation | 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin D3 analogs and uses thereof |
| CA2793727C (en) * | 2010-03-23 | 2017-01-03 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin d3 |
| EP2556053B1 (en) * | 2010-03-23 | 2015-07-29 | Wisconsin Alumni Research Foundation | (20s)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1alpha,25-hydroxyvitamin d3 |
| US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
| AU2012271759B2 (en) * | 2011-06-14 | 2017-02-02 | Wisconsin Alumni Research Foundation | 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5063221A (en) | 1989-04-05 | 1991-11-05 | Chugai Seiyaku Kabushiki Kaisha | Treatment for hyperparathyroidism with use of vitamin d derivatives |
| US5086191A (en) | 1991-05-28 | 1992-02-04 | Wisconsin Alumni Research Foundation | Intermediates for the synthesis of 19-nor vitamin D compounds |
| GB9214202D0 (en) | 1992-07-03 | 1992-08-12 | Leo Pharm Prod Ltd | Chemical compounds |
| EP0619306B1 (en) | 1993-04-05 | 1996-09-11 | Wisconsin Alumni Research Foundation | 19-Nor-vitamin D3 compounds with substituent at 2-position |
| ATE178596T1 (de) | 1994-12-14 | 1999-04-15 | Duphar Int Res | Vitamin-d-derivate und verfahren zur herstellung dieser verbindungen |
| US5945410A (en) * | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
| US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
| GB9721156D0 (en) | 1997-10-06 | 1997-12-03 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
| KR100672886B1 (ko) | 2000-09-08 | 2007-01-24 | 위스콘신 얼럼나이 리서어치 화운데이션 | 1α-히드록시-2-메틸렌-19-노르-호모프레그나칼시페롤 및그의 치료적 용도 |
| US6566352B1 (en) | 2002-02-18 | 2003-05-20 | Wisconsin Alumni Research Foudation | 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| ATE537834T1 (de) * | 2003-08-20 | 2012-01-15 | Wisconsin Alumni Res Found | 2-methylen-19-nor-vitamin d2-verbindungen |
| EP1689412A4 (en) * | 2003-11-25 | 2009-03-11 | Wisconsin Alumni Res Found | VITAMIN D ANALOGUE FOR THE PREVENTION AND TREATMENT OF ADIPOSITAS |
| MX2007006263A (es) | 2004-11-22 | 2007-07-10 | Wisconsin Alumni Res Found | Analogos 2a-metil y 2??-metil de 19,26,27-trinor-(20s)-1a- hidroxivitamina d3 y sus usos. |
| EP1846369A2 (en) | 2004-11-22 | 2007-10-24 | Wisconsin Alumni Research Foundation | 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| AU2005309791A1 (en) | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-methylene-19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and its uses |
| CA2605727A1 (en) * | 2005-05-03 | 2006-11-09 | Wisconsin Alumni Research Foundation | 19,26,27-trinor-1.alpha.,25-dihydroxyvitamin d3 compounds |
| US7803789B2 (en) | 2006-02-02 | 2010-09-28 | Wisconsin Alumni Research Foundation | Vitamin D analog—RAK, methods and uses thereof |
| US7528122B2 (en) | 2006-02-02 | 2009-05-05 | Wisconsin Alumni Research Foundation | Vitamin D analog—NEL, methods and uses thereof |
| AU2007298673A1 (en) | 2006-04-06 | 2008-03-27 | Wisconsin Alumni Research Foundation | 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof |
| NZ575111A (en) * | 2006-09-28 | 2012-02-24 | Wisconsin Alumni Res Found | 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
-
2008
- 2008-07-10 US US12/171,113 patent/US8193170B2/en not_active Expired - Fee Related
-
2009
- 2009-07-09 JP JP2011517601A patent/JP2011527695A/ja active Pending
- 2009-07-09 EP EP09790197A patent/EP2313367A2/en not_active Withdrawn
- 2009-07-09 CA CA2730244A patent/CA2730244A1/en not_active Abandoned
- 2009-07-09 AU AU2009268557A patent/AU2009268557B2/en not_active Ceased
- 2009-07-09 WO PCT/US2009/050048 patent/WO2010006125A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505739A5 (enExample) | ||
| JP2008520689A5 (enExample) | ||
| JP2009532458A5 (enExample) | ||
| JP2008520703A5 (enExample) | ||
| TWI598098B (zh) | 脂質異常症治療劑 | |
| JP2010504995A5 (enExample) | ||
| JP2005529878A5 (enExample) | ||
| JP2011527695A5 (enExample) | ||
| JP2011527699A5 (enExample) | ||
| US8501806B2 (en) | Methods for preventing or reducing colon carcinogenesis | |
| JP2008520705A5 (enExample) | ||
| WO2012009258A3 (en) | Peptidomimetic galanin receptor modulators | |
| JP2008520691A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2011527696A5 (enExample) | ||
| JP2015520233A5 (enExample) | ||
| CN108883088A (zh) | 利用色酮衍生物的上皮间质转化抑制活性的作为纤维化预防及治疗用药剂学组合物的新用途 | |
| JP2008520704A5 (enExample) | ||
| JP2008530110A5 (enExample) | ||
| JP2010504994A5 (enExample) | ||
| JP2021105005A (ja) | 癌治療 | |
| CA2588415A1 (en) | 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses | |
| JP2008520709A5 (enExample) | ||
| JP2008520716A5 (enExample) | ||
| JP2009533483A5 (enExample) |